Erythroid-stimulating agents in cancer therapy: potential dangers and biologic mechanisms.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
, 2009 Sep 1: 27(25)4217-26
Mapping the consequence of Notch1 proteolysis in vivo with NIP-CRE.
Development (Cambridge, England)
, 2007 Feb: 134(3)535-44
A requirement for Notch1 distinguishes 2 phases of definitive hematopoiesis during development.
Blood
, 2004 Nov 15: 104(10)3097-105
Notch pathway is dispensable for adipocyte specification.
Genesis (New York, N.Y. : 2000)
, 2004 Sep: 40(1)40-4
Gamma -secretase inhibitors repress thymocyte development.
Proceedings of the National Academy of Sciences of the United States of America
, 2001 Jun 19: 98(13)7487-91